Innovative Clinical Research Institute (ICRI)

Whittier, California 90603

0 studies enrolling now · 7 studies all time

What they study most

Acute Myelogenous Leukemia, Cancer, Cancer of Pancreas, Colon Cancer, Colorectal Cancer, Follicular Lymphoma, Gastric Cancer, Lung Cancer, Multiple Myeloma, Non Small Cell Lung Cancer, Nonsquamous Non Small Cell Lung Cancer, Ovarian Cancer

Studies at this site

• Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer — Completed
• A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation — Running, not enrolling
• Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers — Completed
• A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer — Completed
• A Study of Melphalan Flufenamide (Melflufen) Plus Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma — Completed
• Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer — Completed
• A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) — Completed